The Results Are In from Quest Diagnostics®
The Results Are In from Quest Diagnostics®
Podcast Description
Physicians routinely diagnose and treat acute and chronic conditions
across multiple clinical areas. Whether it’s a condition studied for
decades or an emerging infection, comprehensive diagnostic testing is
enabling faster and more effective care to drive better patient outcomes.
In fact, most medical decisions are based at least partly on lab testing!
On The Results Are In from Quest Diagnostics®, we are joined by
diagnostics industry leaders who support providers in optimizing care
pathways for their patients. From the latest in cutting-edge research to
the real-world impact of diagnostic testing on treatment journeys, The
Results Are In features can’t-miss stories for those wanting to stay in the
know about the latest innovations in laboratory diagnostics.
Podcast Insights
Content Themes
The podcast focuses on a variety of topics within the field of diagnostics, such as innovative lab testing techniques, the role of biomarkers in early detection of diseases like Alzheimer’s, and the impact of diagnostic choices on patient care. Episodes highlight case studies, like the integration of blood-based biomarkers for Alzheimer’s risk assessment, underscoring trends that shape healthcare delivery.
Physicians routinely diagnose and treat acute and chronic conditions
across multiple clinical areas. Whether it’s a condition studied for
decades or an emerging infection, comprehensive diagnostic testing is
enabling faster and more effective care to drive better patient outcomes.
In fact, most medical decisions are based at least partly on lab testing!
On The Results Are In from Quest Diagnostics®, we are joined by
diagnostics industry leaders who support providers in optimizing care
pathways for their patients. From the latest in cutting-edge research to
the real-world impact of diagnostic testing on treatment journeys, The
Results Are In features can’t-miss stories for those wanting to stay in the
know about the latest innovations in laboratory diagnostics.
In this episode of Results are In by Quest Diagnostics, Amanda Benson is joined by Dr. Michael Racke, Medical Director for Neurology at Quest Diagnostics, to discuss the groundbreaking role blood-based biomarkers play in assessing Alzheimer’s disease risk. Dr. Racke shares his expert insights on how these biomarkers are revolutionizing early risk detection and diagnosis, offering primary care physicians a proactive tool to identify Alzheimer’s before cognitive symptoms appear. From the evolution of Alzheimer’s diagnostics to the practical application of plasma-based tests, Dr. Racke explains how integrating these tests into routine health visits can enable earlier interventions and better patient outcomes. He also discusses how blood-based biomarkers, in conjunction with digital cognitive assessments, are improving the sensitivity of Alzheimer’s screenings. This episode is a must-listen for anyone interested in the future of Alzheimer’s diagnostics and the power of early detection in cognitive health.
Follow Us
Twitter @QuestDX
Facebook @QuestDiagnostics
Instagram @QuestDiagnostics
LinkedIn @QuestDiagnostics
Presented by Quest Diagnostics
www.questdiagnostics.com
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.